Cargando…
Differential Cytokine Responses in Hospitalized COVID-19 Patients Limit Efficacy of Remdesivir
A significant proportion of COVID-19 patients will progress to critical illness requiring invasive mechanical ventilation. This accentuates the need for a therapy that can reduce the severity of COVID-19. Clinical trials have shown the effectiveness of remdesivir in shortening recovery time and decr...
Autores principales: | Chan, Yi-Hao, Young, Barnaby E., Fong, Siew-Wai, Ding, Ying, Goh, Yun Shan, Chee, Rhonda Sin-Ling, Tan, Seow-Yen, Kalimuddin, Shirin, Tambyah, Paul A., Leo, Yee-Sin, Ng, Lisa F. P., Lye, David Chien, Renia, Laurent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275132/ https://www.ncbi.nlm.nih.gov/pubmed/34262564 http://dx.doi.org/10.3389/fimmu.2021.680188 |
Ejemplares similares
-
Persistent Symptoms and Association With Inflammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 Patients
por: Ong, Sean Wei Xiang, et al.
Publicado: (2021) -
Conserved longitudinal alterations of anti-S-protein IgG subclasses in disease progression in initial ancestral Wuhan and vaccine breakthrough Delta infections
por: Goh, Yun Shan, et al.
Publicado: (2022) -
The place for remdesivir in COVID-19 treatment
por: Young, Barnaby, et al.
Publicado: (2021) -
Safety and potential efficacy of cyclooxygenase‐2 inhibitors in coronavirus disease 2019
por: Ong, Sean Wei Xiang, et al.
Publicado: (2020) -
Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity
por: Amrun, Siti Naqiah, et al.
Publicado: (2020)